about
SPPL2a and SPPL2b promote intramembrane proteolysis of TNFalpha in activated dendritic cells to trigger IL-12 productionFrom flies' eyes to our ears: mutations in a human class III myosin cause progressive nonsyndromic hearing loss DFNB30Nuclear myosin VI enhances RNA polymerase II-dependent transcriptionBeethoven, a mouse model for dominant, progressive hearing loss DFNA36.USH3A transcripts encode clarin-1, a four-transmembrane-domain protein with a possible role in sensory synapses.Identifying intracellular Staphylococcus aureus in chronic rhinosinusitis: a direct comparison of techniques.A human nasal explant model to study Staphylococcus aureus biofilm in vitro.Intracellular Staphylococcus aureus: the Trojan horse of recalcitrant chronic rhinosinusitis?Corticosteroids directly reduce Staphylococcus aureus biofilm growth: an in vitro study.The fungal microbiome in chronic rhinosinusitis: richness, diversity, postoperative changes and patient outcomes.Liposome-encapsulated ISMN: a novel nitric oxide-based therapeutic agent against Staphylococcus aureus biofilms.Bacteriophage reduces biofilm of Staphylococcus aureus ex vivo isolates from chronic rhinosinusitis patients.Sinonasal microbiome sampling: a comparison of techniquesDistribution and Inhibition of Liposomes on Staphylococcus aureus and Pseudomonas aeruginosa Biofilm.Fighting sinus-derived Staphylococcus aureus biofilms in vitro with a bacteriophage-derived muralytic enzyme.The bacterial microbiome in chronic rhinosinusitis: Richness, diversity, postoperative changes, and patient outcomes.Th17 Cytokines Disrupt the Airway Mucosal Barrier in Chronic Rhinosinusitis.Innate lymphoid type 2 cells in chronic rhinosinusitis.Taking the Silver Bullet Colloidal Silver Particles for the Topical Treatment of Biofilm-Related Infections.Reduced Innate Immune Response to a Staphylococcus aureus Small Colony Variant Compared to Its Wild-Type Parent Strain.TLR response pathways in NuLi-1 cells and primary human nasal epithelial cells.Mind "De GaPP": in vitro efficacy of deferiprone and gallium-protoporphyrin against Staphylococcus aureus biofilms.Subepithelial inflammatory load and basement membrane thickening in refractory chronic rhinosinusitis with nasal polyposis: a histopathological study.Identification of the Bacterial Reservoirs for the Middle Ear Using Phylogenic Analysis.An in vivo safety and efficacy demonstration of a topical liposomal nitric oxide donor treatment for Staphylococcus aureus biofilm-associated rhinosinusitis.Topical colloidal silver as an anti-biofilm agent in a Staphylococcus aureus chronic rhinosinusitis sheep model.Cousins, siblings, or copies: the genomics of recurrent Staphylococcus aureus infections in chronic rhinosinusitis.Long-Term Safety of Topical Bacteriophage Application to the Frontal Sinus Region.Safety and efficacy of topical bacteriophage and ethylenediaminetetraacetic acid treatment of Staphylococcus aureus infection in a sheep model of sinusitis.The microbiome of otitis media with effusion.Staphylococcus aureus biofilm activates the nucleotide-binding oligomerization domain containing 2 (Nod2) pathway and proinflammatory factors on a human sinonasal explant model.Colloidal silver: a novel treatment for Staphylococcus aureus biofilms?Probiotic manipulation of the chronic rhinosinusitis microbiome.Methylglyoxal-augmented manuka honey as a topical anti-Staphylococcus aureus biofilm agent: safety and efficacy in an in vivo model.Staphylococcus Aureus V8 protease disrupts the integrity of the airway epithelial barrier and impairs IL-6 production in vitro.Nano-hemostats and a Pilot Study of Their Use in a Large Animal Model of Major Vessel Hemorrhage in Endoscopic Skull Base Surgery.The prevalence and expression of inherited connexin 26 mutations associated with nonsyndromic hearing loss in the Israeli population.Association of intracellular Staphylococcus aureus with prognosis in chronic rhinosinusitis.Discordant frequencies of tissue-resident and circulating CD180-negative B cells in chronic rhinosinusitis.Staphylococcus aureus impairs the airway epithelial barrier in vitro.
P50
Q24296666-65A27C6B-F587-431A-8776-0FC5282323F3Q24298272-C62F8230-65A5-465E-85FC-3D3ACAFB48C6Q24301373-5F95E27D-0C68-4700-B372-80ED5F08995CQ34114643-56C98D15-E601-441E-8C22-40CF61006964Q34134919-3BB02A14-C554-4640-9E51-E3CAB3F4D77DQ34508989-116C0EA0-BE21-4835-8225-7A8ED834B2C3Q34583710-7EA923B5-3E67-4D65-822D-AAF27EF9F802Q34592432-955160F6-B1F0-49DB-8D09-F009D8482C1FQ34858808-8815C57B-2325-4572-A173-9205026AD512Q35087142-6FC32E51-5233-4212-AEB2-A57A250AB5F8Q35128144-8874D52B-0BE0-4D30-9182-C9BC56D7D701Q35143683-5B80D08D-76EA-4549-8D9D-53DDBF4CD490Q35415588-EA7C1C5F-E7A7-4850-9F1D-00D6A6BEB229Q35678511-F3DB5965-4DB3-4ACD-B922-941B786EE8F7Q35871785-37C8A13A-5EFD-4A1C-AFFF-87BBFA0DCC39Q35921109-8D334BDB-03C5-4BE1-87E4-E7F4DC026450Q36556904-351C8981-1E31-4D36-A87E-FC17E3839A5EQ38645637-15F20364-F2D9-4BD5-A32F-988B26706AD3Q38672933-422620C0-6213-4151-AB1F-BE5EF1B787AAQ38721521-BE40706E-6E6F-46EE-8EEC-894907AF7BD3Q38828214-565D0B79-3395-4953-87F2-8854E07C8B5FQ38902883-93A66B94-4E28-4ED9-ACB2-723A45B596BDQ38942048-19912A04-2D4A-4D2A-900E-F795B5008BF1Q39216308-97DB8B6B-6721-4A91-86FE-3B9670E1675DQ41112387-03CD269A-7DF4-45C7-BC21-CA3ABCAF0CBCQ41509017-99EDA41D-2B8B-4133-8137-797B1E23EC88Q41720698-26B33E8E-46B4-4DC0-8DBE-448C6C8CFB61Q41984634-7B4C4BCA-3BDB-41AC-A0CB-57E6B60E4D69Q42241966-871DCDD6-AF49-4DAD-AD06-FC60D496205CQ46528571-33FB1C04-BB51-469D-AF48-56F4C90EA608Q46931587-08447960-676D-44B7-BE5C-E9D11CB7C511Q46945663-DC27F2A9-EEFF-4840-A4BC-2D4BA3B6C0EBQ46947292-6F3B2F81-700F-459C-8FD9-91A7EAA8CA7CQ46947329-539EB6BC-A4A2-4306-B4FF-76BCCDA8A0D1Q47673432-4CA7FD7B-F31A-4470-AE0D-DC1CD2AEE86EQ47863311-B8513A14-0B25-4988-AF9E-FB2B9B749AACQ47890225-27C970D4-CA7E-4CD5-8B14-DE8EBB5BED59Q50244354-F0FB0AA0-5D6A-4D3B-97D8-EE184A6FDEC8Q50873261-733FCB99-483E-4BD4-A9B9-11336106697CQ51645776-568B8D27-E676-4CC1-BE9D-61E1552E530F
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sarah Vreugde
@ast
Sarah Vreugde
@en
Sarah Vreugde
@es
Sarah Vreugde
@nl
Sarah Vreugde
@sl
type
label
Sarah Vreugde
@ast
Sarah Vreugde
@en
Sarah Vreugde
@es
Sarah Vreugde
@nl
Sarah Vreugde
@sl
prefLabel
Sarah Vreugde
@ast
Sarah Vreugde
@en
Sarah Vreugde
@es
Sarah Vreugde
@nl
Sarah Vreugde
@sl
P106
P21
P31
P496
0000-0003-4719-9785